NCT02455804View on ClinicalTrials.gov

NIRTRAKS Post-Market Study (NIRTRAKS)

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 8, 2016

Primary Completion Date

January 14, 2020

Study Completion Date

January 14, 2020

Conditions
de Novo Stenotic Lesions in Native Coronary Arteries
Interventions
DEVICE

Stenting procedure

All subjects will be treated with the NIRxcell Stent System and followed at 30 days, 9 months and 1, 2 and 3 years post-index stenting procedure. An unscheduled follow up may be conducted as clinically warranted.

Trial Locations (1)

27710

Duke University Health System, Durham

Sponsors

Lead Sponsor

Medinol Ltd.
All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT02455804 - NIRTRAKS Post-Market Study (NIRTRAKS) | Biotech Hunter | Biotech Hunter